Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, et al. Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program. Blood 2013;122:3759-66.
PMID: 24085766


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016